Earnings History Data for Jounce Therapeutics, Inc. (JNCE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-11-2021 PM 7:00 AM ET
(Nov 4)
JNCE Jounce Therapeutics, Inc. 462.63 -0.59 -0.40 -0.73 Jounce Therapeutics EPS misses by $0.15
[11/4/2021 7:26 AM]
9.61 -0.03 
(-0.31%)
9.61 0.0 
(0.00%)
5.03 - 14.84 240,824 380,000 1,800
05-08-2021 PM 6:30 AM ET
(Aug 5)
JNCE Jounce Therapeutics, Inc. 265.26 -0.08 -0.38 -0.82 Jounce Therapeutics EPS beats by $0.28, beats on revenue
[8/5/2021 7:10 AM]
5.18 0.07 
(1.37%)
5.11 0.0 
(0.00%)
4.43 - 14.84 248,236 200,000 2,778
04-05-2021 PM 6:30 AM ET
(May 4)
JNCE Jounce Therapeutics, Inc. 483.41 -0.58 -0.37 -0.78 Jounce Therapeutics EPS beats by $0.01, misses on revenue
[5/4/2021 6:38 AM]
8.53 -0.85 
(-9.06%)
8.53 0.0 
(0.00%)
4.30 - 14.84 220,478 250,000 1,997
25-02-2021 PM 7:00 AM ET
(Feb 25)
JNCE Jounce Therapeutics, Inc. 436.37 0.86 0.36 -0.68 Jounce Therapeutics EPS beats by $0.64, beats on revenue
[2/25/2021 6:34 AM]
11.76 0.75 
(6.81%)
11.75 0.74 
(6.72%)
2.85 - 14.08 324,589 178,267 1,194
06-11-2020 PM 6:30 AM ET
(Nov 6)
JNCE Jounce Therapeutics, Inc. 244.98 -0.73 -0.37 2.90 Jounce Therapeutics EPS misses by $0.28
[11/6/2020 7:02 AM]
6.76 -0.92 
(-11.93%)
7.80 0.13 
(1.69%)
2.85 - 11.72 389,205 455,702 3,586
07-08-2020 PM 6:30 AM ET
(Aug 7)
JNCE Jounce Therapeutics, Inc. 163.45 -0.82 -0.72 -0.21 Jounce Therapeutics EPS misses by $0.09
[8/7/2020 6:31 AM]
4.57 -0.24 
(-4.90%)
4.80 0.0 
(0.00%)
2.79 - 10.00 95,568 159,061 6,138
06-05-2020 PM JNCE Jounce Therapeutics, Inc. 173.65 -0.78 -0.64 -0.38 Jounce Therapeutics EPS misses by $0.21
[5/6/2020 6:32 AM]
5.34 0.24 
(4.71%)
5.48 0.14 
(2.62%)
2.79 - 10.00 205,866 244,888 1,100